Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine for Post-Caesarean Analgesia
NCT00621907Phase 3Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Mar 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Levobupivacaine with Placebo (2 arms). Primary endpoint: Analgesic consumption of level 3 at 24 hours. Started Mar 2008; status: completed.
02
Drugs
levobupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00621907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621907.